MetaCap

Dermata Therapeutics Insider Trades

NASDAQ: DRMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.02-0.05 (-4.67%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $1.27K
Sales
1 · $13.09
Shares bought / sold
1.00K / 11
Net activity
Net buying $1,257

Dermata Therapeutics insider activity

Over the last 12 months, Dermata Therapeutics insiders reported 7 transactions on SEC Form 4: 1 open-market purchase and 1 sale. Insiders bought $1,270 and sold $13 worth of stock, for net insider buying of $1,257. The largest seller was Scott Kathleen D., with $13 in reported sales.

The most recent filing shows Van Hoose Kyri K. (SVP, CFO) reporting a transaction in 102,040 shares on Aug 16, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DRMA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

DRMA insider transactions

Dermata Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 16, 2026PROEHL GERALD TPRESIDENT, CHAIRMAN, CEOAward170,068—Form 4
Aug 16, 2026Van Hoose Kyri K.SVP, CFOAward102,040—Form 4
Jun 16, 2026Scott Kathleen D.DirectorSale11$13.09Form 4
Feb 17, 2026Bedoya-Toro Munera Maria ESVP, Regulatory AffairsBuy1,000$1.27KForm 4
Dec 23, 2025PROEHL GERALD TPRESIDENT, CHAIRMAN, CEOAward122,549—Form 4
Dec 23, 2025PROEHL GERALD TPRESIDENT, CHAIRMAN, CEOAward490,196—Form 4
Dec 23, 2025Van Hoose Kyri K.SVP, CFOAward122,549—Form 4
Jan 23, 2025HALE DAVID FDirectorAward78,741—Form 4
Jan 21, 2025FISHER MARYDirectorAward196,851—Form 4
Jan 21, 2025PROEHL GERALD TPresident, CEO and ChairmanAward787,402—Form 4
Jan 21, 2025Van Hoose Kyri K.SVP, CFOAward78,741—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related